Anti-CGRP treatment is safe regarding blood pressure in patients without hypertension. For those with baseline hypertension, anti-CGRP treatment resulted in a small but persistent increase in antihypertensive medications, indicating exacerbation of hypertension. The gene discussed is CALCA; the disease is hypertensive disorder.